Search
CorMedix Inc
CRMDAdd to Watchlist
7.770USD
+0.080+1.04%
Close 09-24 16:00（ET）
609.56MMarket Cap
3.19P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+1.04%
5 Days
-0.26%
1 Month
-6.16%
6 Months
+20.28%
Year to Date
-33.19%
1 Year
-30.87%
Key Figures
7.700Open
8.185High
78.07KVolume
3.19P/E TTM
107.14P/E Dynamic
--Dividend TTM
0.10%Turnover Ratio
7.690Prev. Close
7.620Low
601.79KTurnover
LossP/E Static
1.39P/B
0.00%Div Yield TTM
37.51%ROA
13.02052wk High
33.11Volume Ratio
-17.93MNet Profit
78.45MShares
2.4327EPS TTM
1.46Beta
65.59%ROE
6.13052wk Low
7.35%Amplitude
75.66%Gross Margin
609.56MMarket Cap
-1.03Reward/Risk
3.89%Risk Rate
CorMedix Inc's Score
-0.02vs previous score
Forecast8.40
Financial Health9.32
Technical3.15
Valuation Dimensions9.24
Institutional Confidence5.00
Risk Assessment5.52
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
CorMedix Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
CorMedix Inc Latest Earnings Call Transcripts
CorMedix (CRMD) Q2 2026 Earnings Call: Revenue Hits $101.9M, EBITDA Guidance Raised
CorMedix Q2 2026 revenue reached $101.9 million, adjusted EBITDA was $58.7 million, and management raised full-year EBITDA guidance to $125 million-$140 million.
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
0.33/0.24
Revenue / Forecast
101.93M/95.62M
CorMedix Inc Profile
SectorPharmaceuticals
Ticker SymbolCRMD
Number of employees64
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Deep Track Capital LP | 6.72% |
| BlackRock Institutional Trust Company, N.A. | 6.45% |
| Abdalkader (Shaibatalhamd Aymen) | 5.86% |
| Vanguard Capital Management, LLC | 3.99% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 27.10% |
| Investment Advisor/Hedge Fund | 13.41% |
| Hedge Fund | 10.76% |
| Individual Investor | 7.51% |
Related Instruments
+2.68%
+0.56%
+0.02%
-0.07%
+0.60%
+0.75%
-0.01%
-1.11%
+1.18%
+0.82%
+1.17%
+0.57%
-1.27%
-0.12%
-1.73%
-0.72%
+6.98%
+1.73%
-1.17%
+0.61%
FAQs
What is the current price of CorMedix Inc (CRMD)?
The current price of CorMedix Inc (CRMD) is 7.77.
What is the symbol of CorMedix Inc?
The ticker symbol of CorMedix Inc is CRMD.
What is the 52-week high of CorMedix Inc?
The 52-week high of CorMedix Inc is 13.02.
What is the 52-week low of CorMedix Inc?
The 52-week low of CorMedix Inc is 6.13.
What is the market capitalization of CorMedix Inc?
The market capitalization of CorMedix Inc is 609.56M.
Is CorMedix Inc (CRMD) currently rated as Buy, Hold, or Sell?
According to analysts, CorMedix Inc (CRMD) has an overall rating of Buy, with a price target of 15.33.
What is the Earnings Per Share (EPS TTM) of CorMedix Inc (CRMD)?
The Earnings Per Share (EPS TTM) of CorMedix Inc (CRMD) is 2.43.